ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,486Medicare Part D Prescriptions Filled, Including Refills

Rank: 140 out of 6969

$2.59M Total Retail Price of All Prescriptions

Rank: 17 out of 6969

610 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 610 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

25% of this provider’s 610 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 9,547 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$167 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 444 354 1 2
OMEPRAZOLE 422 297 2 6
HYDROCODONE-ACETAMINOPHEN 368 225 S3 3 3
SIMVASTATIN 333 299 4 1
ZOLPIDEM TARTRATE 331 206 5 16
AMLODIPINE BESYLATE 318 262 6 4
LEVOTHYROXINE SODIUM 286 204 7 5
ANDROGEL 244 108 S3 10 8 281
CITALOPRAM HBR 234 162 9 34
TRUVADA 233 46 10 145
NORVIR 229 66 11 141
LOVASTATIN 227 127 12 15
GABAPENTIN 225 136 13 17
HYDROCHLOROTHIAZIDE 216 137 14 8
ATENOLOL 210 160 15 9
VIREAD 197 52 16 288
TRAZODONE HCL 194 120 17 47
ATORVASTATIN CALCIUM 191 93 18 11
ACYCLOVIR 183 46 19 237
FUROSEMIDE 178 137 20 10
LISINOPRIL-HYDROCHLOROTHIAZIDE 172 156 21 28
CYCLOBENZAPRINE HCL 165 84 R 22 130
METOPROLOL TARTRATE 165 130 22 13
GEMFIBROZIL 161 80 24 85
PRAVASTATIN SODIUM 160 87 25 19
FINASTERIDE 151 127 26 80
METFORMIN HCL 147 125 27 7
CARVEDILOL 146 116 28 25
TRICOR 143 52 29 143
ALENDRONATE SODIUM 142 106 30 14
MELOXICAM 137 99 31 36
SPIRIVA 134 90 32 66
SERTRALINE HCL 128 79 33 38
BUPROPION HCL SR 118 82 34 195
DIOVAN 114 91 35 26
EPZICOM 114 48 35 220
ATRIPLA 113 41 37 238
REYATAZ 111 24 38 189
TAMSULOSIN HCL 104 98 39 23
KALETRA 104 26 39 375
BUSPIRONE HCL 104 70 39 187
TEMAZEPAM 100 100 42 251
ALPRAZOLAM 98 63 43 172
ALLOPURINOL 98 78 43 35
FLUTICASONE PROPIONATE 96 62 45 24
PREZISTA 96 43 45 207
LOSARTAN POTASSIUM 96 84 45 12
ADVAIR DISKUS 96 75 45 45
CIMETIDINE 94 46 49 372
CLOPIDOGREL 92 66 50 48
SULFAMETHOXAZOLE-TRIMETHOPRIM 91 33 51 114
ISENTRESS 88 12 52 192
TESTOSTERONE CYPIONATE 85 18 S3 53 334
DOXAZOSIN MESYLATE 85 79 53 74
TRAMADOL HCL 80 30 55 27
SPIRONOLACTONE 78 68 56 102
PANTOPRAZOLE SODIUM 73 69 57 31
OXYCODONE-ACETAMINOPHEN 73 44 S2 57 135
TERAZOSIN HCL 73 70 57 49
CRESTOR 73 34 57 39
LORAZEPAM 70 61 61 186
AMITRIPTYLINE HCL 70 29 R 61 87
IBUPROFEN 68 25 63 29
PAROXETINE HCL 68 28 63 65
SUSTIVA 67 42 65 387
LEVOFLOXACIN 66 51 66 109
TRIAMTERENE-HCTZ 64 43 67 58
CIPROFLOXACIN HCL 63 45 68 64
VERAPAMIL ER 61 56 69 133
FLUOXETINE HCL 61 54 69 43
FENTANYL 60 29 S2 71 113
MIRTAZAPINE 60 34 71 76
METOPROLOL SUCCINATE 59 33 73 22
CLONAZEPAM 58 36 74 510
TRIZIVIR 58 24 74 575
GLYBURIDE 57 45 R 76 54
WARFARIN SODIUM 56 56 77 20
DIGOXIN 56 56 77 71
PREDNISONE 55 46 79 70
INTELENCE 55 0 79 365
PROAIR HFA 52 34 81 33
CARISOPRODOL 52 13 R 81 69
POTASSIUM CHLORIDE 51 19 83 30
KLOR-CON 10 50 43 84 160
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 1, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.